GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
Lupin Ltd
Lupin Q1 FY2027 Results
RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 06 Aug 2026, 10:08 PM IST  ·  BSE ID: 29e693a7-cb6f-4ede-bc42-04ca67d3df22
View Original BSE Filing (PDF)
💡
In Simple Terms
Lupin's Q1 FY2027 earnings increased, driven by higher sales across its major markets, especially the U.S.
🤖 AI Summary
  • Lupin reported Q1 FY2027 consolidated Profit After Tax (PAT) of INR 14,170 Mn, a 16.0% increase year-over-year.
  • Consolidated Sales for Q1 FY2027 rose 33.3% to INR 82,172 Mn compared to Q1 FY2026.
  • EBITDA increased 42.8% to INR 25,799 Mn in Q1 FY2027, with an EBITDA Margin of 31.4%.
  • U.S. sales grew 42.9% to INR 34,348 Mn, accounting for 42% of global sales.
  • India sales increased 13.9% to INR 23,796 Mn, representing 29% of Lupin’s global sales.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Sales
82,172 INR Mn
↑ 33.3%
EBITDA
25,799 INR Mn
↑ 42.8%
EBITDA Margin (%)
31.4%
↑ 210 bps
PAT
14,170 INR Mn
↑ 16.0%
U.S. Sales
34,348 INR Mn
↑ 42.9%
India Sales
23,796 INR Mn
↑ 13.9%
Investment in R&D
6,077 INR Mn
Net Debt
-28,308 INR Mn
🏢 How This Affects the Company
📈
Business Impact
The company's market position in the U.S. and India is sustained, with U.S. sales contributing 42% and India sales 29% to global sales. Growth in Other Developed Markets and Emerging Markets also expanded the global sales mix.
💰
Financial Impact
Net Profit After Tax increased by 16.0% to INR 14,170 Mn, and EBITDA improved by 42.8% to INR 25,799 Mn. The company maintained a Net Debt of INR -28,308 Mn and a Net Debt Equity of -0.12, indicating a net cash position.
⚙️
Operational Impact
Lupin received 6 ANDA approvals and launched 3 products in the U.S., expanding its U.S. generic market presence to 149 products. Investment in R&D for the quarter was INR 6,077 Mn, or 7.4% of sales.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected as the company's financial performance impacts its overall valuation and future prospects. The improved profitability supports business continuity.
🔍
Management Signal
Management's statements indicate a focus on execution, operational excellence, and sustained investments in technology and innovation for long-term growth.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q2 FY2027 results — assess sustained sales growth across key markets.
U.S. FDA approvals — monitor new product launches and ANDA pipeline progression.
EBITDA margin trend — observe if the margin stabilizes or improves in subsequent quarters.
LOW RISK The filing indicates strong financial performance and a healthy balance sheet, with no immediate red flags.
💡 Investor Takeaway
Lupin reported Q1 FY2027 consolidated Net Profit After Tax of INR 14,170 Mn, up 16.0% YoY from INR 12,215 Mn in Q1 FY2026. Consolidated sales increased 33.3% to INR 82,172 Mn, driven by strong U.S. and Emerging Markets growth.
⚖️ Strengths & Concerns

✅ Positives

  • Consolidated Sales for Q1 FY2027 increased by 33.3% YoY to INR 82,172 Mn, demonstrating significant revenue growth.
  • EBITDA grew by 42.8% YoY to INR 25,799 Mn, and the EBITDA Margin expanded by 210 basis points to 31.4%.

⚠️ Concerns

  • Profit After Tax (PAT) growth of 16.0% was lower than sales and EBITDA growth, impacted by a 209.5% increase in tax expense.
  • EBITDA margin decreased by 410 bps QoQ from 35.5% in Q4 FY2026 to 31.4% in Q1 FY2027.
📅 Company Track Record
Lupin's Q1 FY2027 consolidated net profit of INR 14,170 Mn follows a Q1 FY2026 net profit of INR 12,215 Mn. This also follows FY2026 PAT of INR 63,665.6 million, which had increased 62.0% over FY2025, driven by strong U.S. sales.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Lupin's consolidated Net Profit After Tax in Q1 FY2027?
Lupin's consolidated Net Profit After Tax (PAT) in Q1 FY2027 was INR 14,170 Mn, representing a 16.0% increase compared to INR 12,215 Mn in Q1 FY2026.
What were Lupin's total consolidated sales in Q1 FY2027?
Lupin reported total consolidated sales of INR 82,172 Mn in Q1 FY2027, which is a 33.3% increase from INR 61,638 Mn in Q1 FY2026.
How did Lupin's U.S. sales perform in Q1 FY2027?
U.S. sales for Lupin in Q1 FY2027 were INR 34,348 Mn, up 42.9% compared to INR 24,041 Mn in Q1 FY2026, accounting for 42% of global sales.
What was Lupin's EBITDA for Q1 FY2027?
Lupin's EBITDA for Q1 FY2027 was INR 25,799 Mn, a 42.8% increase from INR 18,063 Mn in Q1 FY2026, with an EBITDA Margin of 31.4%.
What was Lupin's Net Debt position as of June 30, 2026?
As of June 30, 2026, Lupin's Net Debt stood at INR -28,308 Mn, with a Net Debt Equity ratio of -0.12.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.